Pyrimidinedione compounds
USRE50050E1 · kind E1 · reissue
0Cited by
16References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2022 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Mar 19, 2042 |
Classification
- Technology area (CPC —)General
Abstract
Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.